back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-29 14:30 Tx date 2025-07-21 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,170
+17,000 vol $1.01 each |
47,000 | |
| Filed 2025-07-29 14:29 Tx date 2025-07-17 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,700
+30,000 vol $0.99 each |
30,000 | |
| Filed 2025-07-29 14:24 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-05-22 12:41 Tx date 2025-05-16 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Holder: Laevoroc Chemotherapy AG (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,981,445
+9,454,153 vol $0.95 each |
9,454,153 | |
| Filed 2025-05-22 12:37 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Holder: Laevoroc Chemotherapy AG (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-05-22 12:37 Tx date 2025-05-16 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Holder: Laevoroc Immunology AG (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,977,322
+11,555,076 vol $0.95 each |
11,555,076 | |
| Filed 2025-05-22 12:32 Tx date 2025-03-05 |
$HBP
Helix BioPharma Corp. |
Mehrling, Thomas Jorg Heinrich
5 - Senior Officer of Issuer
Holder: Laevoroc Immunology AG (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|